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Abstract
Genome editing techniques have facilitated significant advances in our understanding of fundamental biological
processes, and the Cre-Lox system has been instrumental in these achievements. Driving Cre expression
specifically in injured neurons has not been previously possible: we sought to address this limitation in mice using
a Cre-ERT2 construct driven by a reliable indicator of axotomy, activating transcription factor 3 (ATF3). When
crossed with reporter mice, a significant amount of recombination was achieved (without tamoxifen treatment) in
peripherally-projecting sensory, sympathetic, and motoneurons after peripheral nerve crush in hemizygotes
(65–80% by 16 d) and was absent in uninjured neurons. Importantly, injury-induced recombination did not occur
in Schwann cells distal to the injury, and with a knock-out-validated antibody we verified an absence of ATF3
expression. Functional recovery following sciatic nerve crush in ATF3-deficient mice (both hemizygotes and
homozygotes) was delayed, indicating previously unreported haploinsufficiency. In a proof-of-principle experi-
ment, we crossed the ATF3-CreERT2 line with a floxed phosphatase and tensin homolog (PTEN) line and show
significantly improved axonal regeneration, as well as more complete recovery of neuromuscular function. We
also demonstrate the utility of the ATF3-CreERT2 hemizygous line by characterizing recombination after lateral
spinal hemisection (C8/T1), which identified specific populations of ascending spinal cord neurons (including
putative spinothalamic and spinocerebellar) and descending supraspinal neurons (rubrospinal, vestibulospinal,
reticulospinal and hypothalamic). We anticipate these mice will be valuable in distinguishing axotomized from
uninjured neurons of several different classes (e.g., via reporter expression), and in probing the function of any
number of genes as they relate to neuronal injury and regeneration.
Key words: Activating Transcription Factor 3; gene editing; peripheral nerve; Schwann cells; sensory neurons;
spinal cord injury
Significance Statement
Understanding reactions to neurotrauma and overcoming obstacles to neural regeneration should benefit
from the ability to genetically label or otherwise edit the genome of injured neurons. We sought to achieve
this in mice by driving Cre recombinase expression under the control of activating transcription factor 3
(ATF3), which is robustly induced by axotomy in several populations of peripheral and central neurons.
When crossed with reporter mice, recombination occurred only in injured neurons following sciatic nerve
injury or spinal hemisection. Peripheral nerve injury (PNI)-induced neuronal phosphatase and tensin
homolog (PTEN) excision also resulted in improved regeneration and more complete functional recovery.
These results demonstrate the feasibility and utility of axotomy-induced recombination and represent a new
tool for investigating genetic control of injury responses and regeneration.
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Introduction
Advances in genome editing techniques have created
opportunities to dissect out the function of specific genes
and their contributions to health and disease. Among the
most widely used of these tools is the Cre-Lox system, in
which Cre expression can be restricted spatially, to a
single tissue or population of cells through insertion under
a specific promoter (Wagner et al., 1997; Clausen et al.,
1999; Agarwal et al., 2004), or temporally, by fusing the
protein to a mutated estrogen receptor selective for ta-
moxifen (Indra et al., 1999; Hayashi and McMahon 2002;
Leone et al., 2003). In neurotrauma, the combination of
spatial and temporal control of gene expression has fa-
cilitated the identification of the function of individual
neural cells (Sainsbury et al., 2002; Q. Liu et al., 2010), and
manipulated their phenotype to promote repair of the
damaged nervous system (Park et al., 2008; Sun et al.,
2011). A limitation in applying Cre-Lox to investigations of
neurotrauma is the inability to selectively express Cre in
populations of neurons affected by unique pathologies,
such as tau protein-associated degeneration, immune-
mediated degradation, or simple axotomy. This could
notionally be achieved by taking advantage of a gene that
is highly expressed only when the neuron is degenerating
or axotomized. Pathology-induced recombination would
be of use to both identify the affected cell populations and
to edit those populations’ genetic makeup. Here, we pres-
ent a novel transgenic approach to effecting genome
editing on axotomy via an injury-specific gene.
Activating transcription factor 3 (ATF3) is a transcription
factor that belongs to the basic leucine zipper family
(Liang et al., 1996). ATF3 is an immediate early gene; its
transcription is initiated extremely rapidly following the
appropriate stimulus. ATF3 is considered a reliable
marker of neuronal somata with injured peripheral axons
(Tsujino et al., 2000; Mason et al., 2003); ATF3 mRNA can
be detected after peripheral axotomy as early as 6 h after
injury (Tsujino et al., 2000) and can achieve a 130-fold
increase 72 h after axotomy (Seijffers et al., 2007). Other
genes upregulated following injury include c-Jun and
GAP-43 (Tetzlaff et al., 1991; Broude et al., 1997), but
none are upregulated as fast and prominently as ATF3,
making it the most reliable marker of peripheral nervous
system (PNS) injury. These changes in gene expression
constitute part of the pro-regenerative “cell body re-
sponse” to injury. A loss of ATF3 function has been shown
to reduce the regeneration observed after a peripheral
nerve injury (PNI; Gey et al., 2016).
Damage to the PNS is a common outcome of motor
vehicle accidents, penetrating trauma, and falls (Kouy-
oumdjian, 2006). The PNS has the ability to regenerate
injured axons that result in full functional recovery: how-
ever, despite the theoretical regenerative capacity of the
PNS, clinical PNI often results in permanent disability,
since regeneration is often incomplete when the distance
from the axotomy to the soma is far, the gap between
distal and proximal stumps is large, or the time until
surgical intervention is long. Reports suggest that5% of
all patients admitted to a level 1 trauma center sustained
a PNI (Noble et al., 1998), highlighting the need for
strategies that augment this inadequate regenerative
response.
Phosphatase and tensin homolog (PTEN) is an inhibitor
of the PI3K/AKT/mTOR cell growth and proliferation path-
way (Stambolic et al., 1998). The loss of PTEN function via
viral Cre transfection induces a regenerative response in
corticospinal neurons after a spinal cord injury (K. Liu
et al., 2010), a finding that has been reported in other CNS
axonal injury models (Park et al., 2008). In the PNS, in
which regeneration is more robust but still suboptimal,
PTEN deletion has been shown to have modest augmen-
tative effects on axonal regeneration (Gallaher and Stew-
ard, 2018). This allows for the unique opportunity to
compare a pathology-dependent Cre upregulation strat-
egy with a more traditional viral Cre transfection model.
Here, we present a novel transgenic mouse model that
allows for the selective genetic editing of injured neurons
via the insertion of a Cre-ERT2 construct under the native
ATF3 promoter. We confirm expression of the Cre-ERT2
construct in injured neurons after PNI using a fluorescent
reporter line and we demonstrate that this model may also
be used to effect recombination in select populations of
axotomized CNS neurons. Finally, we show that neuronal
injury-specific Cre-ERT2 expression can be used to func-
tionally alter the regenerative capacity of neurons though
excision of crucial PTEN exons, a proof-of-principle ex-
periment that illustrates the utility and potential of this
model in neurotrauma.
Materials and Methods
Animals
All animal procedures were performed in accordance
with the University of British Columbia and King’s College
London animal care committees’ regulations. All mice
were between two and four months of age and equally
distributed between sexes.
The ATF3-CreERT2 (ATF3cre) strain used was gener-
ated and described by Denk et al. (2015). Briefly, the
Cre-ERT2 construct was inserted directly after the ATG
start codon of the second ATF3 exon followed by a 3’
untranslated region and a polyadenylation tagging se-
quence. For some experiments, this line was subse-
quently crossed to a floxed stop tdTomato Ai14 reporter
line (RRID:IMSR_JAX:007908; Madisen et al., 2010). The
ATF3cre line was also crossed with conditional PTEN de-
letion line (PTENfl/fl) with LoxP sites flanking exon 5 of the
Received January 19, 2019; accepted March 20, 2019; First published March
28, 2019.
The authors declare no competing financial interests.
Author contributions: S.D.H., S.B.M., F.D., and M.S.R. designed research;
S.D.H., L.M.R., and M.S.R. performed research; S.D.H. and M.S.R. analyzed
data; S.D.H., L.M.R., F.D., and M.S.R. wrote the paper.
This work was supported by the International Foundation for Research in
Paraplegia (M.S.R.) and the Wellcome Trust (F.D.).
Correspondence should be addressed to Matt S. Ramer at ramer@icord.org
https://doi.org/10.1523/ENEURO.0025-19.2019
Copyright © 2019 Holland et al.
This is an open-access article distributed under the terms of the Creative
Commons Attribution 4.0 International license, which permits unrestricted use,
distribution and reproduction in any medium provided that the original work is
properly attributed.
Methods/New Tools 2 of 17
March/April 2019, 6(2) e0025-19.2019 eNeuro.org
PTEN gene (RRID:IMSR_JAX:006440; Lesche et al., 2002;
in some cases also crossed with the Ai14 line to deter-
mine recombination efficiency). Mice were maintained
on a mixed C57BL/6J x 129SvEv background. ATF3-
CreERT2 mice are available by request from the labora-
tories of Franziska Denk (King’s College London) and Matt
Ramer (the University of British Columbia).
Surgical procedures
For the sciatic nerve crushes the animals were admin-
istered buprenorphine (0.02 mg/kg; Temgesic) and keto-
profen (5 mg/kg; Anafen) subcutaneously for prophylactic
analgesia. Once anaesthetized with isoflurane (5% induc-
tion, 2–3% maintenance; Fresenius Kabi Canada Ltd.),
the sciatic nerve was exposed by blunt dissection and
crushed for 15 s (thrice, 5 s each) with fine #5 forceps at
the sciatic notch. For the brachial nerve crush the same
anesthetic and analgesic protocols were used. The distal
brachial plexus was exposed in the upper forelimb, the
median radial, and ulnar nerves were crushed with fine
forceps. Tamoxifen (Sigma) was dissolved in wheat germ
oil (Denk et al., 2015) and injected at a concentration of 75
mg/kg at the time of injury. Pure anti-estrogen ICI 182780
(Tocris) was delivered by gavage the day before, the day
of, and the day after injury (20 g dissolved in sunflower
oil). For the 2-d regeneration assays, the injury site was
marked with forceps dipped in graphite (ThermoFisher).
For retrograde tracing, 1 l of 5% Fluorogold (Santa Cruz
Biotechnologies) dissolved in 50:50 DMSO:PBS (Sigma-
Aldrich) was injected intraneurally immediately before in-
jury with a 10-l Hamilton syringe (Sigma-Aldrich).
Spinal hemisection was also conducted with the same
anesthetic and analgesic protocols outlined above. A mid-
line incision was made over the lower cervical/upper
thoracic spinal cord, and the C8 and T1 laminae were
removed. A 25-gauge needle was inserted dorso-ventrally
at the midline between the C8 and T1 spinal segments to
allow relatively atraumatic entry of one blade of a pair of
microscissors. The cord was laterally transected with mi-
croscissors; after hemostasis was established, the mus-
cle and skin were closed in layers with sutures. Mice were
killed 7 d later.
Functional outcomes
To investigate the following anatomic and functional
recovery outcomes we employed a transgenic line with
only the Atf3 and Pten alleles altered (i.e., without reporter
to avoid potential confounds associated with high tdto-
mato expression). Specifically, in the first set of experi-
ments we compared ATF3/, ATF3/cre, and ATF3cre/cre
mice to determine similarities to previous knock-out mod-
els (Gey et al., 2016). In the second, set we compared
ATF3/cre:PTEN/ mice with ATF3/cre:PTENfl/fl to com-
pare axotomy-induced PTEN deletion with virally-me-
diated PTEN deletion (Gallaher and Steward, 2018).
Behavioral testing
Reflex withdrawal or crossed extension (i.e., a nocifen-
sive response) on strong toe pinch was assessed in mice
lightly anesthetized with 2% isoflurane. On loss of righting
reflexes, each animal was removed from the induction
chamber and placed prone on a table. To confirm light
anesthesia, the base of a contralateral toe was pinched
with curved serrated forceps. If there was no initial re-
sponse, the other toes on the same foot were pinched in
succession until either a response occurred, or there was
an escape attempt. If a nocifensive response occurred,
the ipsilateral toes were pinched starting with the first and
ending with the fifth digit. As mice are prey species, they
are prone to thanatosis (playing dead), and can suppress
nocifensive withdrawal as they emerge from anesthesia.
As such, a contralateral toe was pinched again following
ipsilateral toe trials. An absence of a contralateral nocif-
ensive response was almost always followed within 5 s by
escape, and so the test was repeated. The test was also
repeated if the mouse regained consciousness while the
ipsilateral paw was being assessed. The presence or
absence of a response to each ipsilateral toe pinch was
recorded. If pinch to a particular toe elicited a response 2
d in a row, recovery was assigned to the first.
For the grasping assay the mouse was suspended
upside-down from a wire cage lid and the grasping ability
of the hindpaw was assessed and scored. Scores were
assigned using the following semi-quantitative metric: un-
directed paw placement  0, directed paw placement 
1, occasional grasp  2, consistent grasp  3. Both tests
were conducted every other day starting on the third
postoperative day until the experimental endpoint (day
28).
Electromyography
Four weeks following injury, mice were anesthetized
with urethane (3 g/kg in dH2O), and their sciatic nerves
were exposed at mid-thigh. The nerves were bathed in
paraffin oil and draped across a pair of silver wire hook
electrodes (anode-cathode distance: 1 mm). EMG needle
electrodes were placed subcutaneously over the lateral
aspect of the hindpaw; one at the calcaneus, the other
just proximal to the base of the 5th digit (over the abduc-
tor digiti minimi muscles). The nerve stimulated with 200
s square wave current pulses using a stimulus generator
(Master 9, A.M.P.I.) and stimulus isolator (A.M.P.I.). Sig-
nals were amplified using a Dual Bio-amp connected to a
16 channel Powerlab (ADInstruments). Signals were sam-
pled at 40 kHz and filtered using LabChart7 software.
After establishing appropriate electrode polarity, current
pulses were delivered at increasing intensities until an
EMG signal became apparent, and threshold current was
recorded. The maximum EMG signal was then obtained,
and the latency and amplitude of the first positive peaks
were recorded.
Tissue processing
Mice were transcardially perfused with phosphate buff-
ered saline followed by 4% paraformaldehyde (Thermo-
Fisher). Once dissected, tissue was postfixed overnight in
4% paraformaldehyde, then overnight again in 20% su-
crose (ThermoFisher) in 0.1 M phosphate buffer. The tis-
sue was then frozen in Cryomatrix (ThermoFisher) and
sectioned at 20 m (DRG and sciatic nerve) or 50–100 m
(spinal cord). In some cases (Fig. 1), whole sympathetic or
sensory ganglia were stained and imaged. All sections
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Figure 1. Axotomy-induced recombination in peripherally-projecting neurons. A, Validation of an ATF3-specific antibody. The Novus
antibody (NBP1-85816) produces a positive signal in nuclei of axotomized sensory neurons in ATF3/mice, but not ATF3cre/cre mice.
Note that the Santa Cruz antibody (C-19) labels neuronal nuclei in in the latter (inset), indicating non-specific staining. B, C, Axotomy
induced reporter expression in sensory (DRG), sympathetic (stellate ganglion, SG), and motoneurons 4 d after injury. D, Reporter
expression in sensory axons and motoneurons one week after injury. E, Preventing CreERT2 translocation from cytoplasm to nucleus
with ICI 182780 reduces recombination in ATF3 cells (by 50%). F, Recombination efficiency 16 d after injury was calculated by
expressing the proportion of tracer-filled somata (labeled at the time of injury) that were also reporter (tdtomato)-positive. G,
Recombination efficiencies at 4 and 16 d after injury (n  3 for each time point) for DRG and motoneurons. Images in panels A, B,
E were taken from whole mounts, those in C, D, F from cryosections.
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were blocked in 10% normal donkey serum with 0.2%
Triton X-100 plus 0.02% sodium azide in PBS. Sections
were incubated overnight with primary antibodies: rabbit
anti-ATF3 (1:400, Santa Cruz SC-188), rabbit anti-ATF3
(1:500, Novus NBP 1-85816), rabbit anti-SCG10 (1:1000,
Novus NBP 1-49461), rabbit anti-PTEN (1:400, Cell Sig-
naling 9188), and mouse anti-PTEN (1:200, Cell Signaling
14642). Sections were incubated for 2 h with the appro-
priate secondary antibodies at a concentration of 1:1000:
Alexa Fluor 488 donkey anti-rabbit (Invitrogen A21206),
and Alexa Fluor 488 donkey anti-mouse (Jackson Immu-
noResearch 715-545-151). Slides were cover-slipped
with ProLong Gold with DAPI (Invitrogen).
Image acquisition and quantification
All images were acquired with a Zeiss LSM 800 confo-
cal microscope using Zen (Blue) software. Recombination
efficiency 4 d after lesion was determined by dividing the
number of ATF3-plus-tdtomato neuronal nuclei by the
total number of ATF3 neuronal nuclei. The 16-d recom-
bination efficiency was calculated by dividing the number
of tracer-positive neuron cell bodies by the total number
of reporter-positive cell bodies. All image processing and
quantification was done using ImageJ (Fiji version 2.0.0-
rc-66/1.52b).
Both PTEN antibodies produced specific staining, but
with high background, varying depending on tissue ex-
amined (DRG and spinal cord). After comparing both
antibodies across all tissues, our analyses relied on the
Cell Signaling 9188 antibody for the DRG images and the
Cell Signaling 14642 for the ventral root images. PTEN
immunoreactivity in the DRG was quantified by measuring
the mean pixel intensity of the entire cell layer of the DRG.
In the spinal cord, PTEN immunoreactivity was weak in
motoneurons, but intense in motor axons on either side of
the ventral root exit zones, and so we focused our atten-
tion there. PTEN immunoreactivity in ventral root axons
was determined by selecting for tdtomato axons and
measuring the PTEN intensity of each axon.
To determine the regeneration density and distance
along the sciatic nerve one best 20-m-thick section (i.e.,
lacking folds, bubbles or other sectioning artifacts) was
selected for each animal, which was then fully imaged
(z-stack and tiled). The stack was orthogonally projected
into a single image through its entire depth. The images
were then processed to generate binary overlays. The
average density of SCG10 immunopositive axons along
the width of the nerve was measured and then averaged
over 100-m increments.
Statistics
All statistical analyses were conducted using Prism 7
(GraphPad). We used a one-way ANOVA followed by
Tukey’s multiple comparison test to compare PTEN im-
munoreactivity among DRGs (ipsilateral and contralateral
from ATF3-CreERT2 mice with and without floxed PTEN.
We used the Kolmogorov–Smirnov goodness-of-fit test to
compare PTEN immunoreactivity in tdtomato axons be-
tween ATF3-CreERT2 tdtomato reporter mice with and
without floxed PTEN. Differences in axonal regeneration
between ATF3-CreERT2 mice with and without floxed
PTEN were determined on cumulative axon densities over
2-mm increments from the crush injury using either a
one-way ANOVA followed by Dunnett’s multiple compar-
ison test (three groups) or an un-paired two-tailed t test
(two groups). For toe pinch, we compared proportions of
animals with five sensate digits (i.e., complete nocifensive
recovery) over time following injury using a log-rank (Man-
tel–Cox) test. The same test was used to compare pro-
portions of animals which showed consistent grasping
with the injured hindpaw. For EMG data, we compared
ipsilateral and contralateral values (threshold, latency,
amplitude) within groups using paired t tests. Because we
used males and females (which differ in size), for
between-group comparisons we used unpaired t tests on
ipsilateral/contralateral ratios.
Results
ATF3-driven injury-induced recombination
The Novus ATF3 antibody labeled the injured wild-type
mice (ATF3/) ipsilateral DRG neurons but did not label
the same ipsilateral DRG neurons in the homozygous
mutant mice (ATF3cre/cre; Fig. 1A). However, the Santa
Cruz antibody did label the injured ipsilateral DRG neu-
rons in the ATF3cre/cre mice, suggesting that it is not
specific to ATF3 but another, injury-dependent protein as
there was no neuronal labeling of any contralateral DRGs
(Fig. 1A).
ATF3-driven recombination was exceedingly rare in the
uninjured nervous system (Fig. 1B,C), although it was
noted that uninjured recombination appeared to be more
prevalent in older mice (data not shown). Four days after
PNI, there was a robust tdtomato signal in the neuronal
cell bodies in axotomized DRGs, stellate (sympathetic)
ganglia (Fig. 1B), and ventral motor pools (Fig. 1C,D) in the
ATF3/cre Ai14 reporter mice without the administration of
tamoxifen. Tdtomato expression was only present in neu-
rons, and only in those with nuclear ATF3 immunoposi-
tivity (Fig. 1B,C).
ATF3 expression is maximal at 4 d after injury but
declines in sensory and motoneurons between 10 and 20
d (Tsujino et al., 2000). In 4-d lesions, we calculated the
proportion of ATF3-positive DRG and motor neurons that
were also tdtomato-positive (Fig. 1B,G). For 16-d lesions,
we identified injured neurons by fluorogold labeling (in-
jected at the time of injury), and determined the proportion
that were also tdtomato labeled (Fig. 1F,G). In the DRG,
recombination efficiencies were (mean  SEM) 53  2%
(4 d) and 76  3% (16 d). For motoneurons, the efficien-
cies were 45  2% (4 d) and 65  3% (16 d). When the
estrogen receptor  antagontist (ICI) was administered
the amount of neuronal recombination was reduced by
almost 50% (from 53  2% to 28  1%, p  0.05, n  3
mice per group; Fig. 1E), demonstrating that recombina-
tion was due to leak of the CreERT2 construct into the
nucleus as a result of inadequate cytoplasmic anchoring.
In the injured distal stump of the sciatic nerve, the
Novus ATF3 antibody showed a uniform and punctate
ATF3 signal that was attributable to white blood cells (Fig.
2A). When only the secondary antibody was used the
same signal was present and not localized to the nucleus
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of the putative white blood cells indicating that the anti-
body signal was an artifact, and that there was no ATF3
upregulation in the injured sciatic nerve (Fig. 2B).
In the uninjured sciatic nerve, long, spindle shaped cells
that morphologically resemble Remak Schwann cells
(RSCs; Gomez-Sanchez et al., 2017) were tdtomato and
therefore had expressed ATF3 at some point in their lifetime
(Fig. 2C). Seven days after axotomy, there was an increased
density of these tdtomato RSCs (Fig. 2D), although they
were not positive for ATF3 immunolabeling. On closer in-
spection 4 d after injury, we found multiple examples of
tdtomato RSCs undergoing all phases of mitosis (Fig. 2E),
suggesting that the increased density was not due to an
injury induced upregulation of ATF3 but instead was the
result of proliferation of previously-labeled cells.
ATF3’s role in peripheral regeneration and functional
recovery
Before employing the ATF3cre line to edit the genes of
injured neurons to manipulate the regenerative response
we first wanted to characterize the effect of losing one or
both copies of the Atf3 allele. Since the Cre insert prema-
turely terminates the ATF3 coding sequence, the ATF3cre
allele is notionally non-functional.
To determine whether loss of the Atf3 allele attenuated
functional recovery after PNI we examined behavioral
recovery up to 28 d following sciatic crush, and electro-
myographical (EMG) activity at the experimental endpoint.
We found that for both the pinching and grasping
assays that the ATF3cre/cre group had significantly di-
minished functional recovery (p  0.0046 for pinch, p 
0.0189 for grasp; Fig. 3A,B). The performance of
ATFcre/ mice was intermediate for both assays (p 
0.0012 for pinch, p  0.0049 for grasp) suggesting a
gene dosage effect (the amount of functional transcript
affects the level of recovery).
In terminal EMG experiments, we found that the ATF3cre/cre
group had significantly longer peak latencies (p  0.0003;
Fig. 3E), and smaller compound muscle action potentials
(p  0.002; Fig. 3F) when comparing ipsilateral/contralat-
Figure 2. Axotomy does not induce ATF3 in Schwann cells. A, Cryosections from injured DRG (inset) and distal sciatic nerve from the
same mouse processed for ATF3 immunohistochemistry (Novus NBP1-85816). B, Punctate staining in the nerve proved to be
non-specific fluorescence of leukocytes (note non-nuclear signal in the absence of primary antibody). C, In intact sciatic nerves, cells
morphologically identical to Remak cells had at some point undergone recombination. D, Following injury, their numbers increased.
E, This was attributable to their proliferation in the injured nerve (as opposed to ATF3 induction and subsequent recombination). C=,
D=, Magnification of areas outlined in C and D demonstrate the spindle shaped morphology characteristic of Remak cells.
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Figure 3. Loss of ATF3 function delays functional recovery following sciatic nerve crush. A, B, The rate of functional recovery
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eral ratios to the controls, indicating more complete mus-
cle reinnervation in ATF3/ mice. There were no
differences in activation thresholds (Fig. 3D). Surprisingly
the ATFcre/ group resembled the ATFcre/cre group in EMG
measures, displayed significantly longer peak latencies (p
 0.008; Fig. 3E), and smaller compound muscle action
potentials (p  0.04; Fig. 3F) when comparing ipsilateral/
contralateral ratios to the controls providing further evi-
dence of a gene dosage effect.
The above data unequivocally demonstrate delayed
functional recovery (which can only be attributable to
regeneration of injured axons given the absence of ATF3
expression in uninjured neurons) in ATF3-deficient mice.
We then asked when differences in regeneration could be
discerned between genotypes anatomically. To this end
we assayed axonal regeneration along the sciatic nerve 2
and 3 d after crush by taking a single section (one that
lacked sectioning artifacts like tears or folds) and imaged
through its full 20-m depth) for analysis. Two days after
sciatic nerve crush, cumulative axon density was not yet
different between ATF3/, ATF3cre/, and ATF3cre/cre
groups (Fig. 4A,B). Three days after sciatic nerve crush, a
significant difference was detected in cumulative axonal
density at 2–4 mm distal to the injury site between
ATF3/ and ATF3cre/cre groups (p  0.0200), and the
ATF3/cre group tested positive as a significant interme-
diary between groups (p  0.0108; Fig. 4C,D). These
anatomic results further support our findings that loss of
one or both copies of the ATF3 allele diminishes regen-
eration after PNI.
ATF3-driven injury-induced PTEN knock-down
To determine whether the ATF3/cre line can excise
floxed endogenous genes, we crossed it to a floxed Pten
line, crushed the sciatic nerve, and measured PTEN ex-
pression 28 d after injury. Three sections each from five
animals were used for analysis. High background with
both PTEN antibodies rendered precise estimates of re-
combination efficiency difficult, but the antibody labeled
small-diameter DRG neurons, as reported previously by
Gallaher and Steward (2018). There was no reduction in
PTEN immunoreactivity between the ipsilateral and con-
tralateral DRG cell layers in control animals (Fig. 5A) indi-
cating that injury itself does not change PTEN expression.
For reasons unknown, but possibly due to the leaky Cre-
ERT2 construct, there was a significant difference in
intensity measurements between genotypes on the con-
tralateral (uninjured) side. Nevertheless, there was a sig-
nificant reduction in PTEN expression on the ipsilateral
side compared to the contralateral side of ATF3/cre
PTENfl/fl mice (p 0.0113) indicating that ATF3 driven Cre
expression successfully excises the PTEN gene (Fig.
5A,B). The non-specific background PTEN antibody in-
tensity was determined from sections from ATF3/cre
PTEN/ mice in which PTEN-positive DRG neuronal so-
mata were excluded from regions of interest (i.e., the ROIs
were the negative of the PTEN-positive neurons). PTEN
immunoreactivity in ATF3/cre PTENfl/fl mice was no dif-
ferent from background.
Spinal motoneurons were weakly PTEN-immuno-
reactive, and although somata were less readily identifi-
able if they were also tdtomato-positive (Fig. 5C),
background staining precluded reliable analysis in the
ventral horn. We therefore examined PTEN expression in
the ipsilateral ventral roots (which were intensely PTEN-
immunoreactive on either side of the ventral root exit
zone) 7 d after sciatic nerve crush in reporter mice with
ATF3/cre and PTENfl/fl or PTEN/ alleles. Four control
animals and three experimental animals were used (three
sections from each). We found that PTEN expression was
significantly reduced (p  0.0001) in the axons that also
expressed tdtomato in the PTENfl/fl group compared to
controls (Fig. 5D).
ATF3-driven PTEN excision improved functional
recovery
To determine whether the ATF3/cre driven Pten exci-
sion was robust enough to effect enhanced functional
recovery after PNI we examined behavioral recovery over
a month following sciatic crush, and EMG activity at the
experimental endpoint. For behavioral analysis the control
group had 14 animals in it and the experimental group had
nine. There were no differences in sensory (pinch) or
sensorimotor (grasping) assays between the ATF3/cre
PTENfl/fl and control groups (Fig. 6A,B), as has been
reported previously (Gallaher and Steward, 2018).
In terminal EMG experiments, however, we found that
the ATF3/cre PTENfl/fl group had a significantly lower
EMG activation threshold (p  0.0001; Fig. 6E), shorter
peak latencies (p  0.040; Fig. 6F), and larger compound
muscle action potentials (p  0.003; Fig. 6G) when com-
paring ipsilateral/contralateral ratios to the controls, indi-
cating more complete muscle reinnervation in mice
lacking PTEN.
Enhanced functional recovery in PTEN deficient mice
implies more robust axonal regeneration. We were again
curious as to when axonal regeneration following ATF3-
driven injury induced Pten excision might be detected
histologically following sciatic crush injury. Six animals
continued
(nocifensive reflex withdrawal to a toe pinch and presence of any grasping ability) was reduced in mice lacking both wild-type ATF3
alleles (log rank Mantel–Cox test). Haploinsufficiency was also suggested by the statistically-significant trend from wild-type to
homozygous knock-in (log rank Mantel–Cox test), n  7, n  9, and n  8 for ATF3/, ATF3/cre, and ATF3cre/cre, respectively. C,
Representative EMG traces from ipsilateral and contralateral sides of an ATF3/mouse 28 d after sciatic nerve crush, and composite
traces from seven ATF3/ mice and seven ATF3cre/cre mice. D, EMG thresholds did not differ between genotypes (paired t test). E,
F, While absolute latencies and amplitudes did not differ between genotypes (paired t test), their ipsilateral/contralateral ratios
(correcting for mouse size) indicated reduced conduction velocity (E) and extent of reinnervation (F) in mice lacking one or both
wild-type ATF3 alleles (unpaired t test), n  6, n  7, and n  6 for ATF3/, ATF3/cre, and ATF3cre/cre, respectively.
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Figure 4. Loss of ATF3 function modestly reduces axonal regeneration following sciatic nerve crush. A, B, There was no difference
in axonal regeneration 2 d following injury between ATF3/, ATF3/cre, and ATF3cre/cre mice (n  7, n  6, and n  6, respectively,
groups were compared with a one-way ANOVA on cumulative densities). C, D, ATF3cre/cre mice exhibited significantly diminished
axonal regeneration 3 d following injury 2–4 mm distal to the injury compared to ATF3/ mice (n  5 for both groups, one-way
Methods/New Tools 9 of 17
March/April 2019, 6(2) e0025-19.2019 eNeuro.org
were used in each group and a single section (lacking
sectioning artifacts, and imaged through its full 20-m
depth) was taken for analysis. Two days after sciatic nerve
crush, axon density plotted as a function of distance was
obviously increased in ATF3/cre PTENfl/fl over that in
ATF3/cre PTEN/ mice, and the cumulative density at 2
continued
ANOVA followed by Dunnett’s multiple comparison test). The hemizygous group (n  4) tested positive as a significant intermediary
between both control and ATF3 null groups (post hoc test for trend). Dotted line indicates distal border of crush site, 500 m from
the edge of the block. Scale bars: 500 m.
Figure 5. Axotomy-induced PTEN deletion in sensory and motoneurons. A, B, Axotomy results in significant loss of PTEN expression
in the DRG. Arrows in A indicate small PTEN-positive DRG neurons. The PTEN antibody results in high background staining in all
animals, to which PTEN immunoreactivity is reduced in axotomized DRGs of ATF3/cre:PTENfl/fl mice (B; one-way ANOVA followed
by Dunnett’s multiple comparison test, n  5 for both groups). C, PTEN immunoreactivity is weak in all motoneurons, rendering
difficult confirmation of axotomy-induced knock-down. However, ventral root (VR; large arrow) axons close to the ventral root exit
zone were intensely immunopositive, single arrows indicate axons that were both tdtomato and PTEN positive, whereas double
arrows indicate recombination without PTEN immunoreactivity. In sections of ventral roots, we were able to demonstrate a significant
decrease in PTEN immunoreactivity in tdtomato-positive axons (D; Kolmogorov–Smirnov goodness of fit test), n  4 and n  3 for
ATF3/cre:PTEN/ and ATF3/cre:PTENfl/fl, respectively. Scale bars: 50 m (A), 100 m (C), 10 m (E).
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Figure 6. Axotomy-induced PTEN deletion and improves functional recovery following sciatic nerve crush. A, B, While there was no
difference in recovery of reflex nociception or grasping in mice with floxed PTEN alleles (log rank Mantel–Cox test, n  14 and n 
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mm was statistically greater (p  0.0008; Fig. 7). This
demonstrates that the ATF3/cre line is able to edit the
genes of injured neurons with enough efficacy to produce
anatomic differences in regeneration.
ATF3-driven recombination after CNS injury
After confirming that the ATF3cre line is capable of
efficient recombination that can selectively edit genes the
genes of injured neurons after PNI we wanted to deter-
mine whether the same line was applicable to CNS injury.
Six ATF3cre/:Ai14 reporter mice underwent a C8/T1 lat-
eral spinal hemisection, were killed 7 d after injury, and
recombination throughout the entire CNS was character-
ized. In the spinal cord, several tracts were reliably la-
beled, these included putative rubrospinal, raphespinal,
reticulospinal, and vestibulospinal descending tracts (Fig.
8C,D). Additionally, ascending neurons were tdtomato;
based on anatomic position these are likely to be spino-
thalamic spinocerebellar neurons (Fig. 8E,F). In the cervi-
cal cord, rostral to the injury site, there was a substantial
amount of recombination in primary afferents innervating
the dorsal horn (Fig. 8C). Four deep brain nuclei were
consistently reporter-positive, these were the rubrospinal,
reticulospinal, vestibulospinal, and paraventricular hypo-
thalamic nuclei (Fig. 9A–E). There were examples of ATF3
immunolabeled and tdtomato-positive neurons in each of
these nuclei (Fig. 9F).
Discussion
The expression of Cre recombinase has for the most
part been restricted to either developmentally distinct
subpopulations of cells via its insertion under specific
promoters or to distinct physical regions by viral transfec-
tion. Selective cellular genetic modification of neurons
based on functional state is an attractive and important
refinement to this approach. Guenthner et al. (2013), for
example, used a genetic labeling technique controlled by
neuronal activity. In this case, recombination was driven
by promoters for the immediate-early genes Fos and Arc,
upregulated as part of the “excitation-transcription” neu-
ronal response to synaptic activity initiated by CREB
phosphorylation. Here, we present a novel transgenic
mouse line that expresses Cre only once peripherally-
projecting neurons have been axotomized by inserting its
construct into the native ATF3 locus. We demonstrate a
substantial amount of recombination (50% by 4 d after
continued
9 for ATF3/cre:PTEN/ and ATF3/cre:PTENfl/fl, respectively), EMG responses (C–G) indicated enhanced recovery of neuromuscular
function. C, D, Representative EMG traces from ipsilateral and contralateral sides of an ATF3/cre:PTEN/ mouse 28 d after sciatic
nerve crush (C) and composite traces from eight ATF3/cre:PTEN/ mice and six ATF3cre/cre:PTENfl/fl mice. E–G, Ipsilateral/
contralateral ratios of EMG thresholds (E), peak EMG latencies (F), and maximum CMAP amplitudes (G) all indicated more complete
muscle reinnervation 28 d after injury; n  8 and n  6 for ATF3/cre:PTEN/ and ATF3/cre:PTENfl/fl, respectively, averages were
compared using paired t tests and ipsilateral/contralateral ratios with unpaired t tests.
Figure 7. Axotomy-induced PTEN deletion and anatomic regeneration following sciatic nerve crush. A, B, Axonal regeneration 2 d
subsequent to sciatic nerve crush (dotted line) was significantly enhanced in ATF3/cre:PTENfl/fl mice. In C, bar graphs represent the
cumulative density of SCG10 immunoreactivity from 0 m (the distal extent of the crush site) to 2000 m; n  6 for both groups and
cumulative densities were compared using an unpaired t test. Scale bars: 500 m.
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Figure 8. Axotomy-induced recombination one week following spinal hemisection: spinal cord. A, Two examples of the injury site from
separate animals in longitudinal section. Insets show consistently-recombining ipsilaterally-projecting neurons near Clarke’s column below
the injury. B, Cartoon of transverse section of the hemisected spinal cord illustrating relative positions of positionally and morphologically
distinguishable recombined neurons (colored dots correspond to examples in C–F). C, Examples of recombination after injury in cervical
(top left), lumbar (two examples middle and bottom-left), and thoracic (top right). The most consistent findings were small ipsilaterally-
projecting neurons in the thoracic cord (C’), and large neurons contralateral to injury from just lateral to area X to the ventral gray matter in
the lumbar cord (C’’). Arrows in C’, C’’ indicate midline-crossing axons. Arrow pointing to tdtomato axons in dorsal cervical white matter
indicates probable rubrospinal (RST) and/or raphespinal tracts. Arrows pointing to reporter-positive axons in ventral white matter indicate
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injury, rising to65–80% by 16 d) in injured sensory, motor,
and sympathetic neurons that is selective to axotomy. This
injury-dependent Cre expression is restricted to the neurons
that have been axotomized, is rare in uninjured controls, and
absent in peripheral glial cells. Furthermore, we show that
axotomy-induced Cre expression can excise floxed genes
continued
probable reticulospinal (RtST) and vestibulospinal (VST), and an unknown descending projection (?) tracts rostral to the injury, and
spinothalamic (STT) and possible dorsal spinocerebellar [DSCT(?)] below the injury (thoracic and lumbar sections). D, Neurons
in Clarke’s column ipsilateral to the hemisection. E, F, Large and small, respectively, putative spinothalamic tract neurons
contralateral to the hemisection. Arrows in E, F indicate commissural axons; cc, central canal.
Figure 9. Hemisection-induced recombination in supraspinal neurons one week after injury. A, Paraventricular hypothalamic nucleus,
descending part. B, Red nucleus.C, Vestibulospinal nucleus (the genu of the facial nerve is indicated by VII).D, Reticulospinal neurons
(RtS) and raphespinal neurons (arrow), and the rubrospinal tract (RST). E, Reporter-expressing axons in the medial longitudinal
fasciculus (conveying descending projections of reticulospinal and vestibulospinal axons). F, Examples of ATF3-positive, tdtomato-
positive and tdtomato-negative neurons in the paraventricular hypothalamic nucleus (PHN), red nucleus (RN), vestibulospinal nucleus
(VSN), and reticulospinal neurons (RtS).
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with sufficient efficacy to significantly effect anatomic regen-
eration and functional recovery.
It is important to note that despite the Cre recombinase
being anchored to a mutated estrogen receptor (ERT2) we
have achieved significant recombination without the ad-
ministration of tamoxifen. This can be attributed to the
“leakiness” of the ERT2 construct where the ERT2 protein
overwhelms its cytoplasmic anchor and translocates to
the nucleus without tamoxifen (or its metabolites) binding.
The high degree of tamoxifen-independent recombination
we report is likely driven by massive upregulation of ATF3
in the PNS after injury: the Atf3 gene (and hence Cre-
ERT2) is highly transcribed once the neuron is axoto-
mized, and there is a greater likelihood of ERT2 leak and
subsequent recombination. Reduction of recombination
by ICI 182780 (Fig. 1) provides an opportunity to titrate
recombination due to leakiness.
We did not use tamoxifen to improve the recombination
efficiency of the model, as it has been previously reported
that tamoxifen administration, at the standard dose of 75
mg/kg, upregulates ATF3 without injury (Denk et al.,
2015). Notionally it is possible that a lower dose of tamox-
ifen would not induce ATF3 expression, but would still
improve the recombination efficiency after injury, although
this dose has yet to be determined. Regardless, the effi-
ciencies achieved in this report due to ERT2 leak remain
sufficient to excise Pten and significantly improve ana-
tomic regeneration and functional recovery.
The potential utility of our model is strengthened by
similarities to previous manipulations using different tech-
niques. A study by Gallaher and Steward (2018) investi-
gated the effect of Pten deletion following axotomy in the
sensory neurons that innervate the sciatic nerve. They
excised Pten through a more traditional intraganglionic
injection of an AAV Cre vector into the L4 and L5 DRG.
Their study and ours agree on three key results: (1) PTEN
immunohistochemistry preferentially labels small diame-
ter sensory neurons, (2) PTEN deletion increased axonal
regeneration along the sciatic nerve 3 d after axotomy,
and (3) PTEN deletion after sciatic nerve crush did not
significantly improve sensory functional recovery. The
ATF3-CreERT2 line has several distinct advantages over
more traditional Cre delivery models; the technical viral
transfection setup is not necessary and Cre can be ex-
pressed in neuronal populations that may not be amena-
ble to local injection. Moreover, the ATF3-ERT2 line allows
for the selective editing of only injured neurons where a
viral Cre transfection does not preclude the possibility of
Cre expression in uninjured neurons.
Using a homozygous knock-in (i.e., null mutant), we
tested the validity of two reported ATF3-specific poly-
clonal antibodies: Novus (NBP 1-85816) and Santa Cruz
(C-19). ATF3 signal was expectedly absent in the ATF3
null ipsilateral DRG after axotomy when using the Novus
antibody. However, signal was still present in both the
control and ATF3 null ipsilateral (but not contralateral)
DRG when tested with the Santa Cruz antibody suggest-
ing that is not specific to ATF3, but likely another injury-
dependent protein. This could call into question some of
the conclusions made by the over 150 articles that have
used this antibody. We then used the Novus ATF3 anti-
body to investigate ATF3 expression in the injured sciatic
nerve. Despite the appearance of putative ATF3 upregu-
lation, we were able to determine that this signal was
restricted to white blood cells, non-nuclear, and in fact
due to background fluorescence. Clements et al. (2017)
reports Schwann cell ATF3 mRNA expression in the un-
injured sciatic nerve which is then reduced on injury,
which appears to contradict our observations of a lack of
ATF3-driven recombination in normal Schwann cells but
supports our finding of a lack of injury-dependent glial cell
ATF3 expression. To obtain these data the Schwann cells
needed to be dissociated, purified, and then sorted before
sequencing. Given ATF3’s role as a stress response im-
mediate early gene it is certainly plausible that this base-
line ATF3 expression is due to the FACS process and not
in fact expressed in the in vitro uninjured nerve, this has
indeed proven to be an issue in other cell types, such as
muscle (van den Brink et al., 2017). Histologic evidence of
ATF3 mRNA upregulation following nerve injury is also
unconvincing (Hunt et al., 2004). We therefore conclude
that ATF3 is not upregulated in peripheral glia after injury
cells, contrary to previous reports. This finding further
strengthens the usefulness of the model as any axotomy-
dependent Cre upregulation is restricted to neuronal
populations.
Tdtomato-positive RSCs increased in density following
sciatic nerve injury. RSCs are a subtype of Schwann cell
that are non-myelinating but still ensheathe small caliber
axons to form Remak bundles (Harty and Monk, 2017).
Gomez-Sanchez et al. (2017) characterized this subtype
of Schwann cells using sporadic permanent fluorophore
labeling. These cells are spindle shaped, can be branched,
and are250m in length; all of which are characteristics of
the sciatic nerve cells found to undergo injury-independent
recombination in the ATF3cre Ai14 reporter line. The absence
of ATF3 immunoreactivity in these cells, along with the high
numbers of RSCs that can be observed undergoing mitosis
4 d after injury show that their increase in density is due
to cellular division rather than injury-induced ATF3-cre-
mediated recombination.
The ATF3cre/cre null mutant also allowed us to test the
effect of a loss of ATF3 function in PNS regeneration early
after injury. While we found no significant differences
between the groups in axonal regeneration along the
sciatic nerve at the 2-d time point, we did find a statisti-
cally significant functional deficit of both ATF3-deficient
groups in both our behavioral and EMG assays. Despite
being a standard time point for this type of analysis, the
lack of significantly different 2-d axonal regeneration
along the sciatic nerve could be because the axons have
not had sufficient time to differentially regenerate enough
to produce a measurable difference. This supports previ-
ous work done by Gey et al. (2016), who found attenuated
regeneration after facial nerve axotomy in ATF3 null mice.
Gey et al. (2016) also showed that when DRG neurons were
cultured in the presence of NGF, any differences in outgrowth
between wild-type and knock-out neurons ATF3 were abol-
ished. NGF is produced early on in the distal transected nerve
(Heumann et al., 1987), and this early abundance may com-
Methods/New Tools 15 of 17
March/April 2019, 6(2) e0025-19.2019 eNeuro.org
pensate for any ATF3-mediated regenerative differences. By 3
dafter injury, however, a clear differencebetweenATF3/ and
ATF3cre/cre mice had emerged, along with evidence again for
haploinsufficiency (the intermediate position of ATF3/cremice).
To our knowledge, this is the first evidence that a loss of ATF3
mitigates functional recovery after injury.
Interestingly the existing literature suggests that ATF3
heterozygotes are haplosufficient (Gey et al., 2016) which
is contrary to our findings of a gene dosage effect. The
fact that the amount of ATF3 transcript affects the func-
tional outcome after peripheral axotomy might seem sur-
prising given how drastically ATF3 is upregulated in
neurons after injury. However, given that ATF3 is a bZIP
transcription factor that dimerizes with itself or other bZIP
transcription factors to affect transcription, it is concep-
tually possible that the binding affinity for the ATF3
dimerization pair responsible for improving regeneration is
low and therefore many copies of ATF3 must be produced
for its pro-regenerative effect. Recent work done be
Rodríguez-Martínez et al. (2017) exemplified this by show-
ing that ATF3’s DNA binding site preference to be highly
dependent on its bZIP dimerization.
ATF3 gene dosage effects (i.e., partial function in hemi-
zygous mice) should not be an impediment to investiga-
tions of functions of other (floxed) genes or sequences
provided the appropriate controls are used. There is sim-
ply a new baseline on which other genetic manipulations
(using ATF3-Cre-driven excision of floxed gene “X”) can
be evaluated. For this reason it is important that any
investigation of the function of gene X compares ATF3/cre:
X/ with ATF3/cre:Xfl/fl (or ATF3/cre:X/fl, for investigat-
ing possible haploinsufficiency of X), as we have done
here substituting “X” with “PTEN.”
ATF3 is not only upregulated after PNI but also after
CNS trauma including spinal cord injury (Huang et al.,
2007), albeit usually meagerly and/or transiently, render-
ing expression patterns difficult to reveal (for review, see
Hunt et al., 2012). As such we wanted to determine
whether CNS neurons could be accessed genetically via
ATF3-cre-mediated recombination after a lateral spinal
cord hemisection. We observed consistent recombination
in four deep brain nuclei (rubrospinal, reticulospinal, ves-
tibulospinal, and hypothalamic) and their projecting axons
and in at least two putative ascending tracts (spinocere-
bellar and spinothalamic). There was no recombination
observed in the injured corticospinal tract, but this is not
surprising given that it takes intracortical axotomy to in-
duce ATF3 in corticospinal neurons (Mason et al., 2003):
the magnitude of upregulation of regeneration associated
genes (of which ATF3 is) have been documented to be
dependent on the distance from the axon transection to
the soma (Fernandes et al., 1999).
The mammalian PNS is able to regenerate after injury,
unlike the CNS where regeneration does not occur. This
positions the PNS as an excellent model for study to
better understand what is necessary for mammalian neu-
ronal regeneration. The ability to edit the genes of injured
neurons and further dissect what is necessary and/or
sufficient to produce this regeneration is of obvious value,
and is now possible with the ATF3cre transgenic line. ATF3
is also expressed in injured neurons after spinal cord
injury (Huang et al., 2007; Wang et al., 2015; Darlot et al.,
2017), traumatic brain injury (Förstner et al., 2018), and
ischemic stroke (Song et al., 2011), making the line useful
to scientists interested in the neuronal response to each
of those pathologies.
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